RxDoctor Payments DataLook up a doctor →

William Trattler, MD

Ophthalmology · Miami, FLNPI 1093730996

Payments from drug & device makers

$579,613in general payments, 2019–2025

Across 1,334 payments — averaging $434.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$148K
  • Johnson & Johnson Surgical Vision, Inc.$46K
  • Alcon$46K
  • Lensar, Inc.$44K
  • Kala Pharmaceuticals, Inc.$40K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$36K
  • plus $219K from 51 others
$5,250in research payments, 2019–2025

Across 1 payment — averaging $5250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$5K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bausch & Lomb Americas Inc.194$148,281
Johnson & Johnson Surgical Vision, Inc.53$46,241
Alcon143$45,874
Lensar, Inc.45$44,448
Kala Pharmaceuticals, Inc.59$40,098
Bausch & Lomb, A Division Of Bausch Health US, LLC62$35,628
Sun Pharmaceutical Industries Inc.120$26,245
AbbVie(2 entities)91$23,710
Tarsus Pharmaceuticals, Inc.30$19,168
Novartis39$17,150
Sight Sciences, Inc.58$17,050
Carl Zeiss Meditec, Inc.23$15,832
Beaver-visitec International, Inc.8$15,527
Shire North American Group Inc19$13,326
Dompe US, Inc.21$11,295
Biotissue Holdings Inc.28$9,755
Glaukos Corporation21$7,633
Alcon Research LLC11$7,070
Omeros Corporation9$4,685
Oculus, Inc.3$4,500
Mallinckrodt Hospital Products Inc.65$3,745
Thea Pharma Inc.17$2,986
Harrow Eye, LLC20$2,895
Amgen(2 entities)10$2,447
Eyevance Pharmaceuticals LLC19$2,331
Eyepoint US, Inc.4$1,887
Oyster Point Pharma, Inc.34$1,571
NEW World Medical,inc.6$1,316
Nordic Pharma, Inc.1$1,050
Aerie Pharmaceuticals, Inc.10$702
Johnson & Johnson Vision Care, Inc.4$688
Carl Zeiss Meditec USA, Inc.8$521
Astellas Pharma US Inc12$502
Regeneron Healthcare Solutions, Inc.12$476
Rayner Intraocular Lenses Limited12$427
Rxsight Inc6$383
Apellis Pharmaceuticals, Inc.12$338
Mallinckrodt Enterprises LLC8$292
Optos, Inc.1$215
Carl Zeiss Meditec Cataract Technology Inc.2$188
Coopervision Inc.2$170
ANI Pharmaceuticals, Inc.6$157
Ocular Therapeutix, Inc.4$136
Merz Pharmaceuticals, LLC5$102
Genentech USA, Inc.3$85
Ortho-clinical Diagnostics, Inc.1$74
Katalyst Surgical, LLC1$72
Staar Surgical Company2$67
Quidel Corporation2$47
Coherus Oncology, Inc.1$44
Alimera Sciences, Inc.1$36
Immunocore Limited1$30
Haag-streit USA, Inc.1$28
Dutch Ophthalmic, USA1$26
Halozyme Inc1$26
Akorn, Inc.1$19
Carl Zeiss Meditec AG1$19

How this compares

$579,613 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida →

Medicare billing

Part B allowed, 2024
$491,446
Medicare patients
1,189
Services billed
2,885

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →